Cancer Epidemiology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Via Franco Gallini 2, 33081, Aviano, PN, Italy.
Epidemiological Department, Azienda Zero, Via J. Avanzo, 35, 35132, Padua, Italy.
J Endocrinol Invest. 2021 Aug;44(8):1679-1688. doi: 10.1007/s40618-020-01475-3. Epub 2021 Jan 18.
Evidence of an increased diagnostic pressure on thyroid has emerged over the past decades. This study aimed to provide estimates of a wide spectrum of surveillance indicators for thyroid dysfunctions and diseases in Italy.
A population-based study was conducted in North-eastern Italy, including 11.7 million residents (20% of the total Italian population). Prescriptions for TSH testing, neck ultrasound or thyroid fine needle aspiration (FNA), surgical procedures, and drugs for hypo- or hyperthyroidism were extracted from regional health databases. Proportions and rates of selected examinations were calculated from 2010 to 2017, overall and by sex, calendar years, age, and region.
Between 2010 and 2017 in North-eastern Italy, 24.5% of women and 9.8% of men received at least one TSH test yearly. In 2017, 7.1% of women and 1.5% of men were prescribed drugs for thyroid dysfunction, 94.6% of whom for hypothyroidism. Neck ultrasound examinations were performed yearly in 6.9% of women and 4.6% of men, with a nearly two-fold variation between areas. Thyroid FNA and thyroidectomies were three-fold more frequent in women (394 and 85 per 100,000) than in men (128 and 29 per 100,000) with a marked variation between areas. Both procedures decreased consistently after 2013.
The results of this population-based study describe recent variations over time and between surrounding areas of indicators of 'diagnostic pressure' on thyroid in North-eastern Italy. These results emphasize the need to harmonize practices and to reduce some procedures (e.g., neck ultrasound and total thyroidectomies) in certain areas.
过去几十年来,甲状腺的诊断压力不断增加。本研究旨在提供意大利广泛的甲状腺功能障碍和疾病监测指标的估计值。
本研究在意大利东北部进行了一项基于人群的研究,包括 1170 万居民(占意大利总人口的 20%)。从区域卫生数据库中提取 TSH 检测、颈部超声或甲状腺细针抽吸(FNA)、手术程序和治疗甲状腺功能减退或甲状腺功能亢进的药物的处方。从 2010 年到 2017 年,计算了选定检查的比例和率,总体上以及按性别、历年、年龄和地区计算。
在意大利东北部,2010 年至 2017 年间,24.5%的女性和 9.8%的男性每年至少接受一次 TSH 检测。2017 年,7.1%的女性和 1.5%的男性开了治疗甲状腺功能障碍的药物,其中 94.6%是治疗甲状腺功能减退的药物。每年有 6.9%的女性和 4.6%的男性进行颈部超声检查,各地区之间的差异几乎是两倍。甲状腺 FNA 和甲状腺切除术在女性中的频率是男性的三倍(每 10 万人中有 394 例和 85 例),各地区之间差异显著。这两种手术在 2013 年后持续减少。
本基于人群的研究结果描述了意大利东北部甲状腺“诊断压力”指标的时间和地区间最近的变化。这些结果强调需要协调实践,并减少某些地区的某些程序(如颈部超声和全甲状腺切除术)。